Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib.

World Journal of Gastroenterology : WJG
Christina WichMatthias Ocker

Abstract

The overall survival for patients with advanced hepatocellular carcinoma (HCC) is still limited. Although the multi-kinase inhibitor sorafenib has recently been approved for this disease, response rates are still low and patients often face dose-limiting toxicities which lead to a reduction in prognosis and treatment success. We here report a patient with metastasized HCC who shows a sustained response for more than 30 mo to sorafenib therapy after failure of a first line therapy with gemcitabine, oxaliplatin and bevacizumab.

References

Mar 11, 1999·The New England Journal of Medicine·H B El-Serag, A C Mason
Oct 13, 1999·Seminars in Liver Disease·J M LlovetJ Bruix
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Aug 31, 2000·Radiology·S KatyalR L Baron
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Apr 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuKeith Stuart
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Jan 11, 2007·Clinical Therapeutics·Ted Shih, Celeste Lindley
May 2, 2007·The Oncologist·Suresh Senan, Egbert F Smit
Jun 5, 2007·Clinics in Liver Disease·E Bugianesi
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Jan 22, 2008·Cancer Chemotherapy and Pharmacology·Jian-Feng LuJacques Gaudreault
May 14, 2008·Reviews on Recent Clinical Trials·Malika KhodjibekovaAdil Al-Nahhas
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nilofer S AzadElise C Kohn
Nov 20, 2008·British Journal of Cancer·T F GretenN P Malek
Apr 21, 2009·Expert Review of Anticancer Therapy·Richard S Finn, Andrew X Zhu
Jun 13, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VerslypeC van de Velde

❮ Previous
Next ❯

Citations

Oct 12, 2011·BMC Medical Research Methodology·Martin W Hoyle, William Henley
Oct 4, 2011·Current Opinion in Cell Biology·Eva Dazert, Michael N Hall
Nov 16, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Stephanie CoulonHans Van Vlierberghe
Nov 12, 2013·Journal of the Egyptian National Cancer Institute·Omar Abdel-Rahman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

The New England Journal of Medicine
Giancarlo Spinzi, Silvia Paggi
Expert Review of Anticancer Therapy
Lorenza Rimassa, Armando Santoro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Abby B SiegelJonathan D Schwartz
Therapeutic Advances in Gastroenterology
Markus Peck-Radosavljevic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Melanie B ThomasJames Abbruzzese
© 2021 Meta ULC. All rights reserved